4D Molecular Therapeutics, Inc.

FDMT Nasdaq SEC CIK 1650648
Follow 4D Molecular Therapeutics Weekly email: filings, results, news

News

2 stories filed under 4D Molecular Therapeutics, grouped into ongoing threads